HER2-positive or Mutated Advanced Colorectal Cancer
1 clinical trials · Condition
◉ Watch HER2-positive or Mutated Advanced Colorectal Cancer
| Record | Firm | Date |
|---|---|---|
| Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard Therapy (NCT05350917) | The First Affiliated Hospital of Zhengzhou University | 2022-06-20 |
Track HER2-positive or Mutated Advanced Colorectal Cancer automatically
Every clearance here is in the API, with alerts when new ones post.